» Articles » PMID: 34758401

Natural-derived Alkaloids Exhibit Great Potential in the Treatment of Ulcerative Colitis

Overview
Journal Pharmacol Res
Publisher Elsevier
Specialty Pharmacology
Date 2021 Nov 10
PMID 34758401
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Ulcerative colitis (UC) is a chronic nonspecific inflammatory disease of colon and rectum with unknown etiology, and the lesions are mainly confined to the mucosa and submucosa of large intestine. The main clinical features of UC include diarrhea, abdominal pain, bloody purulent stool and tenesmus, which seriously affect patients' quality of life. Most of UC patients would receive drug therapy with the exception of surgery for some severe cases. However, current drugs for the treatment of UC have certain limitations including difficulty of radical treatment, adverse reactions and drug resistance after long-term use and exorbitant price of some drugs. The research and development of new drugs for the treatment of UC is urgent, and natural alkaloids are an important source. This research paid close attention to the progress of natural alkaloids from diverse medicinal plants for treating UC in the last twenty years. The potential mechanisms for the natural alkaloids in the treatment of UC was closely related to its modulation of oxidative stress, immune response, intestinal flora and improvement of the gut barrier function. Remarkable effectiveness and safety of natural-derived alkaloids make them potential candidates of UC therapy.

Citing Articles

Coptisine ameliorates colitis in mice by modulating cPLA2/TRPM8/CGRP-1 signaling pathways and strengthening intestinal barrier function.

Wu W, Shu C, Chen L, Wei S, Jing M, Li H Braz J Med Biol Res. 2025; 58:e14349.

PMID: 40053041 PMC: 11884773. DOI: 10.1590/1414-431X2025e14349.


Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells .

Li C, Wang J, Yang H, Luo S, Lu Q Front Pharmacol. 2025; 15():1496874.

PMID: 39840109 PMC: 11747431. DOI: 10.3389/fphar.2024.1496874.


Exploring the Therapeutic Potentials and Molecular Mechanisms of Alkaloids in Ulcerative Colitis: An Integrative Network Pharmacology and Molecular Docking Approach.

Park J, Rarison R, Truong V, Jeong W Prev Nutr Food Sci. 2025; 29(4):441-453.

PMID: 39759821 PMC: 11699582. DOI: 10.3746/pnf.2024.29.4.441.


Down-regulation of interlinked inflammatory signalling cascades by ethanolic extract of Suaeda fruticosa Forssk. ex J.F. Gmel. attenuated in vivo inflammatory and nociceptive responses.

Fiaz M, Elsadek M, Al-Numair K, Chaudhry S, Saleem M, Khan K Inflammopharmacology. 2024; 33(1):311-328.

PMID: 39731702 DOI: 10.1007/s10787-024-01624-7.


Intestinal and hepatic benefits of BBR-EVO on DSS-induced experimental colitis in mice.

Wang W, Han Y, Yin W, Wang Q, Wu Y, Du M Front Microbiol. 2024; 15:1428327.

PMID: 39296302 PMC: 11408294. DOI: 10.3389/fmicb.2024.1428327.